ClinicalTrials.gov
public full text
Public Domain
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)
The overall purpose of this project is to answer the following clinical question: Among Medication-Related Osteonecrosis of the Jaw (MRONJ) patients, do those who are treated with the Pentoxifylline and Tocopherol (PENTO) regimen and standard of care, when compared to those treated with standard of care alone, have decreased areas of exposed bone after one year of treatment?
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Radiographic indicators of disease severity and treatment response in medication-related osteonecrosis of the jaw: A retrospective cone-beam computed tomography-based study using an expanded composite radiographic index#622683
- Efectos de la administración local de pth 1-34 a bajas dosis en un modelo experimental de periodontitis: estudio piloto#989916
- A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia#1351716
- The Indications of First Molar Extraction at Tufts University, School of Dental Medicine#828284
- The Optimal Sequential Therapy After Long Term Denosumab Treatment#1197520
Record · ID 1260667
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive